Vanguard Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-21,587,441
Closed -$2.5B 4604
2023
Q3
$2.5B Buy
21,587,441
+42,917
+0.2% +$4.61M 0.06% 330
2023
Q2
$2.22B Sell
21,544,524
-8,709
-0% -$919K 0.05% 381
2023
Q1
$2.35B Buy
21,553,233
+317,130
+1% +$35.1M 0.06% 352
2022
Q4
$2.42B Sell
21,236,103
-40,559
-0.2% -$3.37M 0.07% 325
2022
Q3
$1.32B Buy
21,276,662
+354,287
+2% +$24.8M 0.04% 468
2022
Q2
$1.67B Buy
20,922,375
+593,498
+3% +$56.2M 0.05% 418
2022
Q1
$2.14B Buy
20,328,877
+190,183
+0.9% +$18.5M 0.05% 401
2021
Q4
$2.17B Buy
20,138,694
+113,681
+0.6% +$12.4M 0.05% 413
2021
Q3
$2.19B Buy
20,025,013
+98,861
+0.5% +$10.3M 0.05% 383
2021
Q2
$1.87B Sell
19,926,152
-578,245
-3% -$53.2M 0.05% 445
2021
Q1
$1.89B Buy
20,504,397
+584,139
+3% +$49.3M 0.05% 410
2020
Q4
$1.46B Buy
19,920,258
+667,408
+3% +$49.6M 0.04% 462
2020
Q3
$1.5B Buy
19,252,850
+1,498,315
+8% +$103M 0.05% 402
2020
Q2
$987M Buy
17,754,535
+209,759
+1% +$8.97M 0.04% 508
2020
Q1
$520M Buy
17,544,776
+455,362
+3% +$15.4M 0.02% 653
2019
Q4
$619M Buy
17,089,414
+91,470
+0.5% +$2.8M 0.02% 727
2019
Q3
$463M Buy
16,997,944
+403,816
+2% +$10.4M 0.02% 831
2019
Q2
$399M Sell
16,594,128
-287,091
-2% -$7.28M 0.02% 909
2019
Q1
$446M Buy
16,881,219
+1,515,341
+10% +$35.9M 0.02% 844
2018
Q4
$300M Buy
15,365,878
+552,037
+4% +$10.8M 0.01% 983
2018
Q3
$290M Buy
14,813,841
+547,099
+4% +$10.4M 0.01% 1140
2018
Q2
$236M Buy
14,266,742
+617,818
+5% +$9.42M 0.01% 1242
2018
Q1
$194M Buy
13,648,924
+173,831
+1% +$2.57M 0.01% 1308
2017
Q4
$197M Buy
13,475,093
+297,663
+2% +$4.18M 0.01% 1310
2017
Q3
$167M Buy
13,177,430
+194,712
+1% +$2.48M 0.01% 1398
2017
Q2
$154M Buy
12,982,718
+233,443
+2% +$2.9M 0.01% 1406
2017
Q1
$188M Buy
12,749,275
+506,596
+4% +$8.2M 0.01% 1260
2016
Q4
$198M Buy
12,242,679
+353,805
+3% +$6.42M 0.01% 1173
2016
Q3
$216M Buy
11,888,874
+1,319,697
+12% +$25.8M 0.01% 1063
2016
Q2
$174M Buy
10,569,177
+737,812
+8% +$11.9M 0.01% 1136
2016
Q1
$163M Buy
9,831,365
+263,703
+3% +$4.61M 0.01% 1145
2015
Q4
$207M Buy
9,567,662
+643,131
+7% +$12.5M 0.01% 978
2015
Q3
$177M Buy
8,924,531
+328,622
+4% +$10.4M 0.01% 1068
2015
Q2
$299M Buy
8,595,909
+3,088,983
+56% +$94.3M 0.02% 819
2015
Q1
$143M Buy
5,506,926
+1,502,079
+38% +$27.5M 0.01% 1253
2014
Q4
$51.6M Buy
4,004,847
+2,241,340
+127% +$28.1M ﹤0.01% 1816
2014
Q3
$21.7M Buy
1,763,507
+88,791
+5% +$1.03M ﹤0.01% 2173
2014
Q2
$26.5M Buy
1,674,716
+419,993
+33% +$5.99M ﹤0.01% 2107
2014
Q1
$19M Buy
1,254,723
+275,879
+28% +$3.12M ﹤0.01% 2206
2013
Q4
$7.46M Buy
978,844
+114,248
+13% +$616K ﹤0.01% 2585
2013
Q3
$2.92M Buy
864,596
+104,740
+14% +$276K ﹤0.01% 2986
2013
Q2
$1.87M Buy
+759,856
New +$1.82M ﹤0.01% 3086

Other funds holding HZNP